DSGN icon

Design Therapeutics
DSGN

Overview Fund Activity

93 hedge funds and large institutions have $124M invested in Design Therapeutics in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 21 increasing their positions, 37 reducing their positions, and 14 closing their positions.

Holders
93
Holders Change
+5
Holders Change %
+5.68%
% of All Funds
1.35%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
19
Increased
21
Reduced
37
Closed
14
Calls
$4K
Puts
$18K
Net Calls
-$14K
Net Calls Change
+$68K

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$2.39M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$5.18M
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$1.63M
4
Wellington Management Group
4
Wellington Management Group
Massachusetts
$864K
5
BBA
5
Baker Bros. Advisors
New York
$6.7M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$3.53M
2
Morgan Stanley
2
Morgan Stanley
New York
$1.93M
3
Goldman Sachs
3
Goldman Sachs
New York
$2.04M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$1.83M
5
PM
5
Prosight Management
Texas
$0
Name Market Value Shares Shares
Change 		Shares
Change %
PMEF
101
Point72 Middle East FZE
United Arab Emirates
– – -9,426 Closed
PAS
102
Point72 Asia (Singapore)
Singapore
– – -2,100 Closed
GWS
103
Glassman Wealth Services
Virginia
– – -293 Closed
Osaic Holdings
104
Osaic Holdings
Arizona
– – -15 Closed
C
105
Covestor
United Kingdom
$0 32 -2 -6%
CFGS
106
Concourse Financial Group Securities
Alabama
– – – –
Carson Wealth (CWM LLC)
107
Carson Wealth (CWM LLC)
Nebraska
$0 1 +1 New
CAL
108
Capital Advisors Ltd
Ohio
$0 12 +12 New
1 2 3 4
5